Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Dirnhofer

Showing results (71-80 of 155) with videos related to

Pageof 16
Sort By:
Histopathology|January 28, 2010
BOB.1, CD79a and cyclin E are the most appropriate markers to discriminate classical Hodgkin's lymphoma from primary mediastinal large B-cell lymphomaSylvia Hoeller, Deborah Zihler, Inti Zlobec, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2002
Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sectionsKatja Specht, Marcus Kremer, Ulrike Müller, et al.
European Journal of Haematology|October 2, 2004
Is higher income and educational status associated with poorer outcome in patients with Hodgkin's disease?Bernhard Holzner, Martina Fischhofer, Georg Kemmler, et al.
Histopathology|March 1, 2012
Inter- and intra-observational variability in immunohistochemistry: a multicentre analysis of diffuse large B-cell lymphoma stainingCharles H Lawrie, Erica Ballabio, Elizabeth Soilleux, et al.
Blood|December 28, 2007
Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic miceRalph Tiedt, Hui Hao-Shen, Marta A Sobas, et al.
The American Journal of Surgical Pathology|December 23, 2004
Expression of epithelial cell adhesion molecule (EpCam) in renal epithelial tumorsPhilip Went, Stephan Dirnhofer, Tiziana Salvisberg, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 14, 2003
Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 casesAlexandar Tzankov, Annette Zimpfer, Ann-Christine Pehrs, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 2, 2005
Rare expression of T-cell markers in classical Hodgkin's lymphomaAlexandar Tzankov, Caroline Bourgau, Alexandra Kaiser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2011
Clonal relationship of classical hodgkin lymphoma and its recurrencesEllen C Obermann, Nadine Mueller, Alexander Rufle, et al.
British Journal of Haematology|May 27, 2009
Angiogenesis and vascular endothelial growth factor-/receptor expression in myeloproliferative neoplasms: correlation with clinical parameters and JAK2-V617F mutational statusMichael Medinger, Radek Skoda, Alois Gratwohl, et al.
Pageof 16

Showing results (71-80 of 155) with videos related to

Sort By:
Pageof 16
Histopathology|January 28, 2010
BOB.1, CD79a and cyclin E are the most appropriate markers to discriminate classical Hodgkin's lymphoma from primary mediastinal large B-cell lymphomaSylvia Hoeller, Deborah Zihler, Inti Zlobec, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2002
Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sectionsKatja Specht, Marcus Kremer, Ulrike Müller, et al.
European Journal of Haematology|October 2, 2004
Is higher income and educational status associated with poorer outcome in patients with Hodgkin's disease?Bernhard Holzner, Martina Fischhofer, Georg Kemmler, et al.
Histopathology|March 1, 2012
Inter- and intra-observational variability in immunohistochemistry: a multicentre analysis of diffuse large B-cell lymphoma stainingCharles H Lawrie, Erica Ballabio, Elizabeth Soilleux, et al.
Blood|December 28, 2007
Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic miceRalph Tiedt, Hui Hao-Shen, Marta A Sobas, et al.
The American Journal of Surgical Pathology|December 23, 2004
Expression of epithelial cell adhesion molecule (EpCam) in renal epithelial tumorsPhilip Went, Stephan Dirnhofer, Tiziana Salvisberg, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 14, 2003
Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 casesAlexandar Tzankov, Annette Zimpfer, Ann-Christine Pehrs, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 2, 2005
Rare expression of T-cell markers in classical Hodgkin's lymphomaAlexandar Tzankov, Caroline Bourgau, Alexandra Kaiser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2011
Clonal relationship of classical hodgkin lymphoma and its recurrencesEllen C Obermann, Nadine Mueller, Alexander Rufle, et al.
British Journal of Haematology|May 27, 2009
Angiogenesis and vascular endothelial growth factor-/receptor expression in myeloproliferative neoplasms: correlation with clinical parameters and JAK2-V617F mutational statusMichael Medinger, Radek Skoda, Alois Gratwohl, et al.
Pageof 16